Wells Fargo & Company Neogenomics Inc Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Neogenomics Inc stock. As of the latest transaction made, Wells Fargo & Company holds 84,391 shares of NEO stock, worth $843,066. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84,391
Previous 78,336
7.73%
Holding current value
$843,066
Previous $1.16 Million
20.35%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$197 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$142 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$65.2 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$61.6 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$61.5 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.26B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...